|
DT-101 Clinical Trials
2 actively recruiting trials across 2 locations
▲ +1 trial since May 2026
Pipeline
Phase 2: 2
Top Sponsors
- Draig Therapeutics Ltd2
Indications
- Major Depressive Disorder (MDD)2
- Depression2
Bentonville, Arkansas1 trial
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Draig Clinical Site
Phase 2
DeSoto, Texas1 trial
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Draig Clinical Site
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.